GSK5460025
/ GSK
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
October 28, 2025
A Study to Investigate the Safety and Preliminary Efficacy of GSK5460025 Alone or in Combination With Other Anti-cancer Agents in Participants With Solid Tumors
(clinicaltrials.gov)
- P1/2 | N=47 | Recruiting | Sponsor: GlaxoSmithKline | Not yet recruiting ➔ Recruiting
dMMR • Enrollment open • Mismatch repair • MSI-H • Colorectal Cancer • Microsatellite Instability • Oncology • Solid Tumor
October 16, 2025
A Study to Investigate the Safety and Preliminary Efficacy of GSK5460025 Alone or in Combination With Other Anti-cancer Agents in Participants With Solid Tumors
(clinicaltrials.gov)
- P1/2 | N=47 | Not yet recruiting | Sponsor: GlaxoSmithKline
dMMR • Mismatch repair • MSI-H • New P1/2 trial • Colorectal Cancer • Microsatellite Instability • Oncology • Solid Tumor
1 to 2
Of
2
Go to page
1